Rein Therapeutics Inc (RNTX:NASDAQ)

$1.2 -0.03 (-2.44%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 50

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Rein Therapeutics Inc (RNTX:NASDAQ) News Sources

‘It’s a wake-up call’: U.S. biotechs discuss why we’ve fallen behind China

The Mercury News

Fed's Goolsbee finds tariff ruling could add more uncertainty

Yahoo Finance

The Russian economy is eating its own muscle to survive as Putin’s war on Ukraine destroys future capacity, former central bank advisor says

Fortune on MSN

RNTX stock
RNTX stock price
RNTX stock price today
RNTX stock prediction
RNTX earnings date
RNTX news
RNTX price
RNTX share
RNTX share price
RNTX shares
RNTX ceo
RNTX premarket
$RNTX
RNTX ticker
RNTX after hours
RNTX stock
RNTX stock price
RNTX stock price today
RNTX stock prediction
RNTX earnings date
RNTX news
RNTX price
RNTX share
RNTX share price
RNTX shares
RNTX ceo
RNTX premarket
$RNTX
RNTX ticker
RNTX after hours

Rein Therapeutics Inc (RNTX:NASDAQ) FAQs

toggle

What is the current price of Rein Therapeutics Inc (RNTX:NASDAQ)?

The current price of Rein Therapeutics Inc (RNTX:NASDAQ) is $1.2.


toggle

Rein Therapeutics Inc (RNTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of Rein Therapeutics Inc (RNTX:NASDAQ) since the previous trading day is $-0.03.


toggle

Rein Therapeutics Inc (RNTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of Rein Therapeutics Inc (RNTX:NASDAQ) since the previous trading day is -2.44%.


toggle

What is This Week's average sentiment score for Rein Therapeutics Inc (RNTX:NASDAQ)?

This Week's average sentiment score for Rein Therapeutics Inc (RNTX:NASDAQ) is 50 out of 100.


toggle

What is This Week's average sentiment for Rein Therapeutics Inc (RNTX:NASDAQ)?

This Week's sentiment for Rein Therapeutics Inc (RNTX:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.